Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PERTUZUMAB Cause Alanine aminotransferase increased? 199 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 199 reports of Alanine aminotransferase increased have been filed in association with PERTUZUMAB (PERJETA). This represents 0.9% of all adverse event reports for PERTUZUMAB.

199
Reports of Alanine aminotransferase increased with PERTUZUMAB
0.9%
of all PERTUZUMAB reports
13
Deaths
74
Hospitalizations

How Dangerous Is Alanine aminotransferase increased From PERTUZUMAB?

Of the 199 reports, 13 (6.5%) resulted in death, 74 (37.2%) required hospitalization, and 13 (6.5%) were considered life-threatening.

Is Alanine aminotransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 199 reports have been filed with the FAERS database.

What Other Side Effects Does PERTUZUMAB Cause?

Diarrhoea (3,343) Off label use (1,886) Fatigue (1,672) Nausea (1,669) Myelosuppression (1,311) Disease progression (1,142) Vomiting (1,096) Dyspnoea (987) Neuropathy peripheral (983) Pyrexia (926)

What Other Drugs Cause Alanine aminotransferase increased?

METHOTREXATE (2,440) RITUXIMAB (1,651) ADALIMUMAB (1,308) TOCILIZUMAB (1,163) ETANERCEPT (1,131) LEFLUNOMIDE (1,099) ACETAMINOPHEN (1,083) REMDESIVIR (1,047) FINGOLIMOD (1,020) INFLIXIMAB (981)

Which PERTUZUMAB Alternatives Have Lower Alanine aminotransferase increased Risk?

PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB PERTUZUMAB vs PETROLATUM PERTUZUMAB vs PEVONEDISTAT PERTUZUMAB vs PEXIDARTINIB PERTUZUMAB vs PHENACETIN

Related Pages

PERTUZUMAB Full Profile All Alanine aminotransferase increased Reports All Drugs Causing Alanine aminotransferase increased PERTUZUMAB Demographics